3SBio (HKSE:01530) 3-Year EBITDA Growth Rate : 22.70% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is 3SBio 3-Year EBITDA Growth Rate?

3SBio's EBITDA per Share for the six months ended in Dec. 2023 was HK$0.48.

During the past 12 months, 3SBio's average EBITDA Per Share Growth Rate was -2.60% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 22.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 10.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of 3SBio was 34.50% per year. The lowest was -2.70% per year. And the median was 16.70% per year.

Competitive Comparison of 3SBio's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, 3SBio's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

3SBio's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3SBio's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where 3SBio's 3-Year EBITDA Growth Rate falls into.

3SBio 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

3SBio (HKSE:01530) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

3SBio 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of 3SBio's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

3SBio (HKSE:01530) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio Inc (HKSE:01530) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

83B:Germany

Address

No. 3 A1, Road 10, Shenyang Economy and Technology Development Zone, Shenyang, CHN, 110027

Website

https://www.3sbio.com

3SBio Inc, or 3SBio, is one of the largest and most established biotech drugmakers in China. In 2021, it reported revenue of CNY 6.3 billion. Approximately 90% of its revenue is derived from four core drugs: TPIAO (rhTPO), Yisaipu (biosimilar of etanercept, a TNF-alpha inhibitor), rhEPO, and Mandi (minoxidil). With the exception of minoxidil, an over-the-counter drug, the others are all older generation biologics. Most of the pipeline candidates are "me-too" drugs and in general are still at an early stage.

3SBio (HKSE:01530) Headlines

No Headlines